How selective is GR 43175? Interactions with functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors
- 30 June 1989
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 340 (1) , 135-138
- https://doi.org/10.1007/bf00169219
Abstract
GR 43175 (3-[2-dimethylamino]ethyl-N-methyl-1H-indole-5 methane sulphonamide) is a novel 5-HT1-like receptor-selective agonist which was reported to be active in the treatment of migraine attacks. The effects of the compound were investigated in radioligand binding studies and in functional models for 5-HT1A, 5-HT1B, and 5-HT1D receptors (inhibition of forskolin-stimulated adenylate cyclase activity in calf hippocampus, rat and calf substantia nigra, respectively) and 5-HT1C receptors (stimulation of inositol phosphate production in pig choroid plexus). GR 43175 displayed the following order of affinity for 5-HT recognition sites (pKD values, -log mol/l, in parentheses): 5-HT1D (7.54) > 5-HT1B (6.35) > 5-HT1A (6.13) ≫ 5-HT1C (4.13) > 5-HT2 (3.67). The same order of potency was observed at functional 5-HT1 receptors, at which GR 43175 acted as a full agonist, with the exception of the 5-HT1C receptor, where the compound was a weak antagonist (pEC50 or pKB values, -log mol/l, in parentheses): 5-HT1D (6.28) > 5-HT1B (6.03) > 5-HT1A (5.57) > 5-HT1C (4.25). The present data show that GR 43175 interacts preferentially as an agonist with 5-HT1B and 5-HT1D receptors. Since 5-HT1B receptors have not yet been identified in human brain, it seems possible that it is the 5-HT1D receptor which is relevant to the reported antimigraine effects of this compound.Keywords
This publication has 13 references indexed in Scilit:
- Centrally acting hypotensive agents with affinity for 5‐HT1A binding sites inhibit forskolin‐stimulated adenylate cyclase activity in calf hippocampusBritish Journal of Pharmacology, 1988
- GR43175, a selective agonist for the 5‐HT1‐like receptor in dog isolated saphenous veinBritish Journal of Pharmacology, 1988
- 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigraEuropean Journal of Pharmacology, 1988
- The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigraNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- Molecular pharmacology of 5-HT1D recognition sites: Radioligand binding studies in human, pig and calf brain membranesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- POSSIBLE BENEFIT OF GR43175, A NOVEL 5-HT1-LIKE RECEPTOR AGONIST, FOR THE ACUTE TREATMENT OF SEVERE MIGRAINEThe Lancet, 1988
- Visualization of a novel serotonin recognition site (5-HT1D) in the human brain by autoradiographyNeuroscience Letters, 1988
- Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sitesBrain Research, 1986
- Species variations in RU 24969 interactions with non-5-HT1A binding sitesEuropean Journal of Pharmacology, 1986
- Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: Radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]KetanserinEuropean Journal of Pharmacology, 1985